Search for a trial

Relation between human islet amyloid polypeptide (hIAPP) and pain phenotype in chronic idiopathic axonal polyneuropathy (CIAP) and diabetic polyneuropathy (DPN) patients

The primary objective of phase 1 is to validate a new ELISA measurement that can determine hIAPP oligomers reliably in plasma, and of phase 2 is to correlate pathogenic oligomer hIAPP (in plasma and skin) with pain and sensory disturbances in CIAP…